drugset / Trial / NCT05361161
Transarterial Chemoembolization With Lipiodol in the Treatment of Initial Unresectable Gastric Cancer (GC)
NaSingle-groupOpen-labelTreatment
Summary
This is a prospective, open-labelled study to evaluate the efficacy and safety of sequential transarterial chemoembolization with lipiodol and neoadjuvant chemotherapy in the treatment of Initial unresectable gastric cancer.
Timeline
- Start
- 2022-06-01
- Primary completion
- 2022-12-01
- Completion
- 2025-12-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Oxaliplatin | Small molecule | — | Other |
| Subject | Raltitrexed | Small molecule | — | Other |
| Subject | THP | Unknown | — | Other |
| Background | lipiodol | Unknown | — | — |